Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Apotex Health Corp. (APTX) Stock Price & Analysis

34 Followers

APTX Stock Chart & Stats

CA$34.48CA$0.78(2.31%)
At close: 4:00 PM EST
C$30C$32.5C$35C$37.5Aug 10Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2
Day’s Range
CAD 33.79 - CAD 34.58
52-Week Range
CAD 26.05 - CAD 40.18
Previous Close
CAD 33.70
Volume
N/A
Average Volume (3M)
318.85K
Market Cap
CAD 7.88B
Enterprise Value
CAD 10.14B
Total Cash (Recent Filing)
N/A
Total Debt (Recent Filing)
N/A
Price to Earnings (P/E)
22.3
Beta
-0.37
Next Earnings
Nov 12, 2026 (Est.)
EPS Estimate
0.36
Last Dividend Ex-Date
Sep 15, 2026
Dividend Yield
0.18%

Bulls Say, Bears Say

Bulls Say

Profitability Turnaround

The shift from losses to solid profitability, alongside materially higher gross and EBIT margins, indicates stronger operating execution and earnings quality. If maintained, the improved margin structure can support reinvestment, absorb moderate revenue pressure, and strengthen cash generation over coming quarters.

Improving Cash Generation

Strong positive operating cash flow and sharply higher free cash flow provide tangible support for the earnings recovery. This cash generation gives Apotex resources to fund launches, pursue productivity initiatives, and reduce debt, although the current debt burden limits how quickly financial flexibility can improve.

Deep Launch Pipeline And Market Position

A multi-year pipeline with a meaningful expected revenue contribution creates visible avenues for product-led growth beyond existing portfolios. First-to-market launches and established Canadian strength can reinforce market position, diversify revenue sources, and support management’s FY27 growth outlook.

Bears Say

Highly Stressed Capital Structure

Debt growth combined with negative shareholders’ equity materially reduces balance-sheet resilience and financial flexibility. Even with improving earnings and cash flow, the stressed structure can constrain investment, increase sensitivity to operating setbacks, and make deleveraging a central requirement for sustained stability.

U.S. And Specialty-generics Weakness

The U.S. decline and sharper specialty-generics contraction show that revenue remains exposed to product-cycle comparisons and portfolio pressure. Loss of prior-year exclusivity benefits, combined with the ophthalmic pause, may weigh on near-term growth while new launches must replace eroding contributions.

Semaglutide Scaling And Competition Risk

Semaglutide is an important growth opportunity, but constrained device and partner capacity could limit the company’s ability to convert demand into revenue. Expected competitor reentry may also reduce the durability of Apotex’s current sole-supplier position and pressure future market share.

Apotex Health Corp. News

APTX FAQ

What was Apotex Health Corp.’s price range in the past 12 months?
Apotex Health Corp. lowest stock price was C$26.05 and its highest was C$40.18 in the past 12 months.
What is Apotex Health Corp.’s market cap?
Apotex Health Corp.’s market cap is C$7.88B.
When is Apotex Health Corp.’s upcoming earnings report date?
Apotex Health Corp.’s next earnings report is estimated for Nov 12, 2026 (not yet confirmed), which is in 1 day.
How were Apotex Health Corp.’s earnings last quarter?
Apotex Health Corp. released its earnings results on Aug 12, 2026. The company reported C$0.7 earnings per share for the quarter, beating the consensus estimate of C$0.312 by C$0.388.
Is Apotex Health Corp. overvalued?
According to Wall Street analysts Apotex Health Corp.’s price is currently Undervalued.
Does Apotex Health Corp. pay dividends?
Apotex Health Corp. pays a Notavailable dividend of C$0.06 which represents an annual dividend yield of 0.18%. See more information on Apotex Health Corp. dividends here
What is Apotex Health Corp.’s EPS estimate?
Apotex Health Corp.’s EPS estimate is 0.36.
How many shares outstanding does Apotex Health Corp. have?
Apotex Health Corp. has 228,499,020 shares outstanding.
What happened to Apotex Health Corp.’s price movement after its last earnings report?
Apotex Health Corp. reported an EPS of C$0.7 in its last earnings report, beating expectations of C$0.312. Following the earnings report the stock price went down -3.617%.
Which hedge fund is a major shareholder of Apotex Health Corp.?
Currently, no hedge funds are holding shares in TSE:APTX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology